These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2731779)

  • 1. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
    Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Truffert J; Mirshahi MC; de Gennes JL; Caen JP
    Haemostasis; 1989; 19(2):83-90. PubMed ID: 2731779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
    Zitoun D; Bara L; Basdevant A; Samama MM
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
    Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1170-6. PubMed ID: 8792771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
    Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Chapman J; Truffert J; Dairou F; De Gennes JL; Caen JP
    Haemostasis; 1989; 19(3):125-30. PubMed ID: 2744628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
    Carvalho de Sousa J; Bruckert E; Soria C; Caen JP
    Nouv Rev Fr Hematol (1978); 1989; 31(1):13-5. PubMed ID: 2915918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
    Moor E; Silveira A; van't Hooft F; Suontaka AM; Eriksson P; Blombäck M; Hamsten A
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):655-64. PubMed ID: 7749878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
    Kario K; Miyata T; Sakata T; Matsuo T; Kato H
    Arterioscler Thromb; 1994 Feb; 14(2):265-74. PubMed ID: 8305419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of coagulation factor VII with the risk of myocardial infarction in the Chinese.
    Cai Q; Chen J; Ma H; Song J; Xu M
    Chin Med J (Engl); 2000 Dec; 113(12):1059-63. PubMed ID: 11776135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on plasma coagulation factor VII (FVII) levels and polymorphisms of FVII gene in patients with coronary heart disease].
    Kang W; Wang H; Xiong L; Wang X; Chu H; Qu B; Liu X; Yin J; Duan B; Yu J; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):457-9. PubMed ID: 12482354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
    Danielsen R; Onundarson PT; Thors H; Vidarsson B; Morrissey JH
    Scand Cardiovasc J; 1998; 32(2):87-95. PubMed ID: 9636964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factor VII for a molecular marker in hypercoagulable state].
    Takamiya O; Okumura N
    Rinsho Byori; 1993 Jan; 41(1):83-7. PubMed ID: 8355413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determinants of plasma factor VII activity in the Japanese.
    Kario K; Narita N; Matsuo T; Kayaba K; Tsutsumi A; Matsuo M; Miyata T; Shimada K
    Thromb Haemost; 1995 Apr; 73(4):617-22. PubMed ID: 7495068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation factor VII and the risk of coronary heart disease in healthy men.
    Junker R; Heinrich J; Schulte H; van de Loo J; Assmann G
    Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1539-44. PubMed ID: 9301633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
    Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin reduces plasma levels of factor VII activity and factor VII antigen in patients with hyperlipidemia.
    Morishita E; Minami S; Ishino C; Kanno M; Uotani C; Asakura H; Matsuda T; Nakao S
    J Atheroscler Thromb; 2002; 9(1):72-7. PubMed ID: 12238641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study.
    Ishikawa S; Kario K; Nago N; Kayaba K; Hiraoka J; Matsuo H; Goto T; Miyamoto T; Tsutsumi A; Nakamura Y; Shimada K; Inoue K; Igarashi M
    Thromb Haemost; 1997 May; 77(5):890-3. PubMed ID: 9184398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis.
    Bladbjerg EM; Münster AM; Marckmann P; Keller N; Jespersen J
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2494-9. PubMed ID: 11073858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of factor VII activity and mass in coronary artery disease of varying severity.
    Suzuki T; Yamauchi K; Matsushita T; Furumichi T; Furui H; Tsuzuki J; Saito H
    Clin Cardiol; 1991 Sep; 14(9):731-6. PubMed ID: 1742907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.